Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ECHOIQ LIMITED Board/Management Information 2022

Nov 9, 2022

64833_rns_2022-11-09_c81d6491-fb60-48f8-bb19-79238b27ba78.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

ASX: EIQ RELEASE

10 November 2022

==> picture [146 x 26] intentionally omitted <==

APPOINTMENT OF JOINT COMPANY SECRETARY

Sydney: AI and Medical Technology Company Echo IQ (the Company) (ASX:EIQ) is pleased to announce the appointment of Adam Uren as Joint Company Secretary of the Company effective immediately.

Adam has 8 years’ experience in the stockbroking and financial services industry having previously worked at Canaccord Genuity (formerly Patersons Securities). Adam is currently a Corporate Advisor at Nexia Perth which has recently acquired Everest Corporate where Adam has been working with a portfolio of listed companies assisting them with their corporate governance and compliance requirements.

Adam will work alongside Jessamyn Lyons who remains in the role of Joint Company Secretary.

For the purpose of ASX listing Rule 12.6 Jessamyn Lyons is the person responsible for communication between the Company and ASX.

  • ENDS -

Authorised for release by the Board of Directors of Echo IQ Limited.

Media Enquiries: Philip Woolff, Chief Operating Officer [email protected] / [email protected] / +61 (0)490 030 620

Investor Enquiries: Andrew Grover, Executive Chair [email protected] / [email protected]

ABOUT ECHO IQ

Echo IQ uses AI-driven technology and proprietary software to improve decision making in Cardiology. The company is based in Sydney, Australia.

==> picture [596 x 114] intentionally omitted <==